Skip to main content
. 2021 May 18;5(4):pkab045. doi: 10.1093/jncics/pkab045

Figure 1.

Figure 1.

Discarded percentage of each weight-based antineoplastic drug and its share in total payment for discarded drugs in 2017, sorted by mean discarded percentages. A) Mean, minimum, and maximum discarded percentage of each weight-based antineoplastic drug calculated from patients’ biometric information linked to drug claims and sorted by mean discarded percentages. A plus sign (+) indicates that fewer than 5 patients in our study cohort received the drug. B) The share of each weight-based antineoplastic drug among total payment for discarded drugs in 2017 varies widely across drugs.